Crossmark

Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100670

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Horiuchi, Kentaro

Kogiso, Tomomi

Sagawa, Takaomi

Taniai, Makiko

Kotera, Yoshito

Egawa, Hiroto

Tokushige, Katsutoshi
Funding

Funding for this research was provided by:

Chugai Pharmaceutical

Dainippon Sumitomo Pharma

Takeda Pharmaceutical Company

Astellas Pharma

Taiho Pharmaceutical
License Information

Text and Data Mining valid from 2022-03-01

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2022-01-12
More Information

This article is maintained by: Elsevier

Article Title: Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100670

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.